BMY Exercise Disclosure
Boerner Christopher S. · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Boerner Christopher S. Chief Executive Officer
BMY
Transaction date
Nov 1, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 2 days later
BMY daily price context
Close on/before transaction
$62.48
Oct 30, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Market Share Units on Common Stock, $0.10 par value
- Quantity / price
- 2,964 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001543747-26-000004
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$107.72K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bristol Myers Squibb Co BMY Current | Exercise | Nov 1, 2026 | $0 |
| Bristol Myers Squibb Co BMY | Exercise | Nov 1, 2026 | $0 |
| Bristol Myers Squibb Co BMY | Other | Nov 1, 2026 | $0 |
| Bristol Myers Squibb Co BMY | Disposition | Nov 1, 2026 | $107.72K |